Renal and Hepatic Impairment Studies: Optimizing Strategies in Clinical Development, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar, the featured speakers will explain how to optimize your clinical development plan for impairment assessment and give insights on the protocol development and eligibility enrollment processes. Attendees will learn about streamlining feasibility assessment to achieve a fast startup and how to conduct a “reduced PK study” and tips for working with dialysis cohorts.

Xtalks Life Science Webinars

As traditional renal and hepatic impairment studies have shifted, efficiently conducting these studies to understand the effect of a treatment and achieve regulatory approval requires a comprehensive, cross-functional strategy.

From study design to feasibility assessment to patient enrollment, many important considerations factor into achieving timely completion of renal/hepatic impairment studies. As traditional renal and hepatic impairment studies have shifted, efficiently conducting these studies to understand the effect of a treatment and achieve regulatory approval requires a comprehensive, cross-functional strategy.

Join this webinar to hear from four specialists in the field as they share their insights for optimizing a clinical development plan, identifying key protocol parameters, best practices for managing the medical and scientific aspects of impairment studies and how to choose the right sites and perform start-up quickly. They will also cover practical considerations for handling the complexity of Phase I studies, conducting a “reduced PK study” per the FDA guidance and working with dialysis cohorts.

Join Jane Royalty, MD, Senior Medical Director, Clinical Pharmacology Services, Covance, Thomas C. Marbury, MD, President, Orlando Clinical Research Center, Jackie Miller-Giles, MS, Senior Clinical Scientist, Clinical Pharmacology Services, Covance and Jasmine Ropers, Senior Project Manager, Covance Clinical Pharmacology Services in a live webinar on Friday, June 19, 2020 at 11am EDT (4pm BST/UK).

For more information or to register for this event, visit Renal and Hepatic Impairment Studies: Optimizing Strategies in Clinical Developmen t.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sydney Perelmutter
Xtalks
+1 (416) 977-6555 x 352
Email >
Visit website